
Biodesix Investor Relations Material
Latest events

Q4 2024
Biodesix
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Biodesix Inc
Access all reports
Biodesix, Inc. acquires and operates diagnostic companies, as well as develops and commercializes diagnostic tests in the areas of lung cancer, malignancies, and other diseases. The company provides a multi-protein blood test, which includes Nodality gene mutational panel for use in non-small-cell lung cancer (NSCLC) patients; and Biodesix Lung Reflex testing platform that analyzes circulating tumor DNA in advanced stage NSCLC patients. Biodesix, Inc. was founded in 2002 and is based in Boulder, Colorado with additional offices in California and Germany.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
BDSX
Country
🇺🇸 United States